Product Description

THYRONORM 112MCG contains Thyroxine which belongs to the group of medicines called Thyroid hormone receptors. It is used as a replacement therapy in the treatment of primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. It is also used as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated papillary or follicular carcinoma (a differentiated thyroid cancer where cancer develops from the follicular cells and grow slowly) of thyroid gland.

Hypothyroidism is a condition in which the thyroid gland doesn’t produce enough thyroid hormone in the blood stream. It is characterized by symptoms such as weakness, increased sensitivity to cold, constipation, dry skin, weight gain, puffy face, hoarseness, and muscle weakness.

Thyroxine is a synthetic form of the body’s natural thyroid hormone which works by replacing the thyroid hormone that thyroid gland fails to produce in sufficient quantity thus treating the symptoms of hypothyroidism.

THYRONORM 112MCG is not recommended for use if you had a heart attack, acute myocarditis (inflammation/ swelling of the heart muscle), or acute pancarditis (general inflammation/ swelling of the heart) recently. It should be used with caution in patients with severe liver disease such as liver cirrhosis, kidney problems such as renal impairment, end-stage renal disease, nephrotic syndrome, renal failure, or the patients with kidney transplant. It should be used with caution in patients with other heart problems, and/or with a history of heart attack. It is not indicated for use in patients with overactive thyroid gland or untreated adrenal insufficiency (inability of adrenal glands to make enough of the hormone cortisol). It should be used cautiously in pregnant and breastfeeding women. THYRONORM 112MCG should be used with caution in children and adolescents (below 18 years of age). Consult your doctor for advice before taking.